bpc-157 half-life human – No Proof Required! | Office for Science and Society BPC-157 – Mark Hyman, MD

8b1), along with a low Tafel slope of 59 mV dec 1 and robust stability, with 95% retention of current density over 24 h (Fig

The right protocol combines: DNA repair to address photoaging at the cellular level with NEOVA DNA Total Repair Copper peptide support to rebuild collagen and elastin with NEOVA Super Eye Lift Serum Daily photoprotection to stop further accumulation with NEOVA SPF formulas Start with the right ingredients, protect against ongoing damage, and give the process time to work

SURMOUNT-4 results: 14% regain after stopping Tirzepatide, but 9.5% stays off

Net effect strongly pro-survival

Any substance that could theoretically support tumor growth deserves extra caution in this population